Loading...
SSY Group Limited
LJUIF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.70
$0.00(0.00%)
SSY Group Limited (LJUIF) Financial Performance & Income Statement Overview
Review SSY Group Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-10.67%
↓ 10.67%
Operating Income Growth
-18.02%
↓ 18.02%
Net Income Growth
-19.53%
↓ 19.53%
Operating Cash Flow Growth
-46.96%
↓ 46.96%
Operating Margin
24.61%
↑ 24.61%
Gross Margin
53.23%
↑ 53.23%
Net Profit Margin
21.11%
↑ 21.11%
ROE
18.87%
↑ 18.87%
ROIC
14.77%
↑ 14.77%
SSY Group Limited (LJUIF) Income Statement & Financial Overview
Review SSY Group Limited's (LJUIF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $2.43B | $3.34B | $3.13B | $3.33B |
| Cost of Revenue | $1.37B | $1.50B | $1.53B | $1.44B |
| Gross Profit | $1.06B | $1.84B | $1.60B | $1.89B |
| Gross Profit Ratio | $0.44 | $0.55 | $0.51 | $0.57 |
| R&D Expenses | $129.45M | $136.52M | $127.85M | $126.30M |
| SG&A Expenses | $550.25M | $898.57M | $728.89M | $1.02B |
| Operating Expenses | $570.59M | $994.17M | $856.75M | $1.14B |
| Total Costs & Expenses | $1.94B | $2.49B | $2.39B | $2.59B |
| Interest Income | $0.00 | $15.79M | $14.28M | $19.64M |
| Interest Expense | $0.00 | $63.16M | $64.66M | $60.75M |
| Depreciation & Amortization | $169.64M | $225.26M | $207.48M | $198.10M |
| EBITDA | $653.56M | $1.09B | $1.09B | $985.47M |
| EBITDA Ratio | $0.27 | $0.32 | $0.30 | $0.28 |
| Operating Income | $494.22M | $849.28M | $742.96M | $747.18M |
| Operating Income Ratio | $0.20 | $0.25 | $0.24 | $0.22 |
| Other Income/Expenses (Net) | -$36.27M | -$25.63M | $69.91M | -$21.79M |
| Income Before Tax | $457.95M | $823.65M | $812.87M | $770.70M |
| Income Before Tax Ratio | $0.19 | $0.25 | $0.26 | $0.23 |
| Income Tax Expense | $80.13M | $125.86M | $133.09M | $121.19M |
| Net Income | $375.41M | $685.74M | $680.005M | $638.61M |
| Net Income Ratio | $0.15 | $0.21 | $0.22 | $0.19 |
| EPS | $0.13 | $0.23 | $0.23 | $0.21 |
| Diluted EPS | $0.13 | $0.23 | $0.23 | $0.21 |
| Weighted Avg Shares Outstanding | $2.96B | $2.97B | $2.97B | $2.97B |
| Weighted Avg Shares Outstanding (Diluted) | $2.96B | $2.97B | $2.97B | $2.99B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan